Renin-angiotensin system inhibitors (RASi) are widely utilized in the area of cardiovascular disease including heart failure, myocardial infarction, and so on due to the ability to reversing the left ventricular remodeling [6, 7]. This evidence concerns the gene REN and heart failure.